Torley Helen — SEC Form 4 filings
SEC reporting owner CIK 1528185. 33 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2024-02-13 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 124 legs across 20 filings — 858,492 shares, $60,943,291 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 164.
- Largest priced transaction: sale of 15,492 shares @ $107.15 ($1,660,030) in HALOZYME THERAPEUTICS, INC., filed 2026-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. (HALO) | PRESIDENT AND CEO, Director | 33 | — | 124 legs · 858,492 sh · $60,943,291 | 164 |
Form 4 filings — Torley Helen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $18.41 · Sale (S): 13,304 @ $107.22 · Sale (S): 6,596 @ $107.82 · Sale (S): 100 @ $108.67 · Option exercise (M): 20,000 @ $18.41 · Sale (S): 14,588 @ $107.01 · +7 more | EDGAR |
| 2026-08-19 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $18.41 · Sale (S): 900 @ $98.96 · Sale (S): 500 @ $100.46 · Sale (S): 2,100 @ $101.77 · Sale (S): 9,000 @ $102.55 · Sale (S): 7,500 @ $103.48 · +11 more | EDGAR |
| 2026-07-09 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 1,923 @ $12.07 · Sale (S): 888 @ $79.28 · Sale (S): 1,035 @ $80.19 · Option exercise (M): 1,923 (derivative) @ $12.07 | EDGAR |
| 2026-06-03 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $12.07 · Sale (S): 1,610 @ $66.39 · Sale (S): 12,989 @ $67.41 · Sale (S): 5,401 @ $68.35 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 16,600 @ $66.31 · +9 more | EDGAR |
| 2026-05-13 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $12.07 · Sale (S): 9,725 @ $64.63 · Sale (S): 3,575 @ $65.46 · Sale (S): 6,700 @ $66.33 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 100 @ $67.85 · +12 more | EDGAR |
| 2026-04-07 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $12.07 · Sale (S): 5,900 @ $63.14 · Sale (S): 4,100 @ $64.02 · Option exercise (M): 10,000 (derivative) @ $12.07 | EDGAR |
| 2026-04-02 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $12.07 · Sale (S): 19,000 @ $65.36 · Sale (S): 1,000 @ $65.71 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 15,800 @ $64.06 · Sale (S): 4,200 @ $64.89 · +2 more | EDGAR |
| 2026-03-04 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $12.07 · Sale (S): 4,100 @ $69.20 · Sale (S): 15,322 @ $69.80 · Sale (S): 578 @ $70.46 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 13,481 @ $68.85 · +7 more | EDGAR |
| 2026-02-24 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 16,757 @ $0 · Tax withholding (F): 9,040 @ $70.98 · Option exercise (M): 22,436 @ $0 · Tax withholding (F): 12,104 @ $70.64 · Option exercise (M): 16,757 (derivative) @ $0 · Option exercise (M): 22,436 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 21,009 @ $0 · Tax withholding (F): 11,334 @ $79.44 · Option exercise (M): 16,875 @ $0 · Tax withholding (F): 9,104 @ $79.44 · Option exercise (M): 51,171 @ $0 · Tax withholding (F): 27,605 @ $79.44 · +3 more | EDGAR |
| 2026-02-11 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 53,847 (derivative) @ $0 · Grant/award (A): 50,013 (derivative) @ $0 · Grant/award (A): 19,807 (derivative) @ $0 · Grant/award (A): 24,985 (derivative) @ $0 · Grant/award (A): 92,714 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $12.07 · Sale (S): 2,551 @ $74.88 · Sale (S): 9,659 @ $75.94 · Sale (S): 7,790 @ $76.73 · Option exercise (M): 20,000 @ $12.07 · Sale (S): 9,900 @ $76.94 · +7 more | EDGAR |
| 2025-12-11 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 165,522 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Gift (G): 25,000 @ $0 · Option exercise (M): 16,569 @ $8.11 · Sale (S): 10,406 @ $68.51 · Sale (S): 5,402 @ $69.44 · Sale (S): 500 @ $70.36 · Sale (S): 261 @ $71.60 · +1 more | EDGAR |
| 2025-11-12 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $8.11 · Sale (S): 19,900 @ $68.71 · Sale (S): 100 @ $69.30 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 4,500 @ $67.89 · Sale (S): 4,000 @ $68.80 · +8 more | EDGAR |
| 2025-10-03 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $8.11 · Sale (S): 11,705 @ $75.11 · Sale (S): 8,295 @ $75.69 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 6,600 @ $70.51 · Sale (S): 10,200 @ $71.28 · +11 more | EDGAR |
| 2025-09-04 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $8.11 · Sale (S): 300 @ $72.48 · Sale (S): 16,288 @ $73.70 · Sale (S): 3,412 @ $74.15 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 9,500 @ $74.22 · +8 more | EDGAR |
| 2025-08-13 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $8.11 · Sale (S): 18,717 @ $63.01 · Sale (S): 1,283 @ $63.60 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 13,042 @ $63.24 · Sale (S): 6,958 @ $64.00 · +6 more | EDGAR |
| 2025-07-10 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $8.11 · Sale (S): 3,598 @ $54.48 · Sale (S): 16,402 @ $55.74 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 19,792 @ $56.43 · Sale (S): 208 @ $57.08 · +6 more | EDGAR |
| 2025-06-24 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $8.11 · Sale (S): 20,000 @ $52.96 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 20,000 @ $52.57 · Option exercise (M): 20,000 @ $8.11 · Sale (S): 4,489 @ $53.11 · +4 more | EDGAR |
| 2025-02-24 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 22,436 @ $0 · Tax withholding (F): 12,081 @ $57.75 · Option exercise (M): 22,436 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 71,038 (derivative) @ $0 · Grant/award (A): 67,027 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 13,092 @ $0 · Tax withholding (F): 7,098 @ $58.29 · Option exercise (M): 71,810 @ $0 · Tax withholding (F): 38,668 @ $58.29 · Option exercise (M): 21,009 @ $0 · Tax withholding (F): 11,313 @ $58.29 · +6 more | EDGAR |
| 2025-02-14 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 24,957 (derivative) @ $0 · Grant/award (A): 20,008 (derivative) @ $0 · Grant/award (A): 23,260 (derivative) @ $0 · Grant/award (A): 96,155 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Gift (G): 10,000 @ $0 | EDGAR |
| 2024-10-09 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $13.87 · Sale (S): 9,100 @ $53.94 · Sale (S): 900 @ $54.57 · Option exercise (M): 10,000 @ $13.87 · Sale (S): 5,981 @ $51.85 · Sale (S): 1,615 @ $53.31 · +3 more | EDGAR |
| 2024-09-26 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $13.87 · Sale (S): 10,000 @ $58.21 · Option exercise (M): 10,000 @ $13.87 · Sale (S): 10,000 @ $56.34 · Option exercise (M): 10,000 @ $13.87 · Sale (S): 10,000 @ $56.10 · +3 more | EDGAR |
| 2024-09-12 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $13.87 · Sale (S): 10,000 @ $59.09 · Option exercise (M): 10,000 @ $13.87 · Sale (S): 10,000 @ $59.09 · Option exercise (M): 10,000 @ $13.87 · Sale (S): 10,000 @ $59.20 · +3 more | EDGAR |
| 2024-08-15 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $13.87 · Sale (S): 10,000 @ $56.25 · Option exercise (M): 10,000 @ $13.87 · Sale (S): 3,263 @ $56.22 · Sale (S): 6,537 @ $57.73 · Sale (S): 200 @ $58.17 · +5 more | EDGAR |
| 2024-02-27 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 93,002 (derivative) @ $0 · Grant/award (A): 89,744 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 21,009 @ $0 · Tax withholding (F): 11,292 @ $36.10 · Option exercise (M): 16,875 @ $0 · Tax withholding (F): 9,070 @ $36.10 · Option exercise (M): 21,009 (derivative) @ $0 · Option exercise (M): 16,875 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 13,092 @ $0 · Tax withholding (F): 7,036 @ $35.91 · Grant/award (A): 32,781 @ $0 · Tax withholding (F): 17,619 @ $35.91 · Option exercise (M): 13,092 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 31,281 @ $0 · Tax withholding (F): 16,943 @ $35.49 · Option exercise (M): 31,281 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1528185 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →